![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SAMM50 |
Gene summary for SAMM50 |
![]() |
Gene information | Species | Human | Gene symbol | SAMM50 | Gene ID | 25813 |
Gene name | SAMM50 sorting and assembly machinery component | |
Gene Alias | CGI-51 | |
Cytomap | 22q13.31 | |
Gene Type | protein-coding | GO ID | GO:0006605 | UniProtAcc | Q9Y512 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
25813 | SAMM50 | P2_cSCC | Human | Skin | cSCC | 3.98e-30 | 7.57e-01 | -0.024 |
25813 | SAMM50 | P4_cSCC | Human | Skin | cSCC | 6.15e-31 | 6.93e-01 | -0.00290000000000005 |
25813 | SAMM50 | P10_cSCC | Human | Skin | cSCC | 7.74e-29 | 7.11e-01 | 0.1017 |
25813 | SAMM50 | cSCC_p9 | Human | Skin | cSCC | 3.19e-05 | 1.24e-01 | -0.1991 |
25813 | SAMM50 | male-WTA | Human | Thyroid | PTC | 9.87e-15 | 3.52e-02 | 0.1037 |
25813 | SAMM50 | PTC01 | Human | Thyroid | PTC | 6.72e-14 | 1.04e-01 | 0.1899 |
25813 | SAMM50 | PTC04 | Human | Thyroid | PTC | 3.53e-05 | 5.58e-02 | 0.1927 |
25813 | SAMM50 | PTC05 | Human | Thyroid | PTC | 2.93e-02 | 1.07e-01 | 0.2065 |
25813 | SAMM50 | PTC06 | Human | Thyroid | PTC | 1.35e-17 | 3.65e-01 | 0.2057 |
25813 | SAMM50 | PTC07 | Human | Thyroid | PTC | 5.41e-35 | 2.89e-01 | 0.2044 |
25813 | SAMM50 | ATC11 | Human | Thyroid | ATC | 2.28e-04 | 3.84e-01 | 0.3386 |
25813 | SAMM50 | ATC12 | Human | Thyroid | ATC | 3.56e-10 | 2.05e-01 | 0.34 |
25813 | SAMM50 | ATC13 | Human | Thyroid | ATC | 9.99e-31 | 4.76e-01 | 0.34 |
25813 | SAMM50 | ATC2 | Human | Thyroid | ATC | 1.37e-05 | 6.86e-01 | 0.34 |
25813 | SAMM50 | ATC3 | Human | Thyroid | ATC | 9.99e-04 | 2.86e-01 | 0.338 |
25813 | SAMM50 | ATC4 | Human | Thyroid | ATC | 5.84e-11 | 2.68e-01 | 0.34 |
25813 | SAMM50 | ATC5 | Human | Thyroid | ATC | 3.01e-25 | 5.28e-01 | 0.34 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003310820 | Esophagus | HGIN | mitochondrial respiratory chain complex assembly | 47/2587 | 93/18723 | 3.15e-17 | 8.60e-15 | 47 |
GO:007259420 | Esophagus | HGIN | establishment of protein localization to organelle | 120/2587 | 422/18723 | 1.73e-15 | 4.00e-13 | 120 |
GO:000683920 | Esophagus | HGIN | mitochondrial transport | 74/2587 | 254/18723 | 1.32e-10 | 1.32e-08 | 74 |
GO:007058520 | Esophagus | HGIN | protein localization to mitochondrion | 43/2587 | 125/18723 | 4.43e-09 | 3.03e-07 | 43 |
GO:007265520 | Esophagus | HGIN | establishment of protein localization to mitochondrion | 41/2587 | 120/18723 | 1.26e-08 | 7.96e-07 | 41 |
GO:000660525 | Esophagus | HGIN | protein targeting | 78/2587 | 314/18723 | 1.08e-07 | 5.47e-06 | 78 |
GO:009015020 | Esophagus | HGIN | establishment of protein localization to membrane | 67/2587 | 260/18723 | 1.96e-07 | 9.57e-06 | 67 |
GO:000700618 | Esophagus | HGIN | mitochondrial membrane organization | 37/2587 | 116/18723 | 4.61e-07 | 2.07e-05 | 37 |
GO:000662620 | Esophagus | HGIN | protein targeting to mitochondrion | 33/2587 | 100/18723 | 7.99e-07 | 3.35e-05 | 33 |
GO:00512057 | Esophagus | HGIN | protein insertion into membrane | 21/2587 | 57/18723 | 1.16e-05 | 3.29e-04 | 21 |
GO:001703817 | Esophagus | HGIN | protein import | 51/2587 | 206/18723 | 1.79e-05 | 4.86e-04 | 51 |
GO:00070076 | Esophagus | HGIN | inner mitochondrial membrane organization | 16/2587 | 38/18723 | 1.82e-05 | 4.93e-04 | 16 |
GO:009015117 | Esophagus | HGIN | establishment of protein localization to mitochondrial membrane | 13/2587 | 30/18723 | 7.76e-05 | 1.74e-03 | 13 |
GO:00512049 | Esophagus | HGIN | protein insertion into mitochondrial membrane | 10/2587 | 25/18723 | 1.12e-03 | 1.36e-02 | 10 |
GO:0072594110 | Esophagus | ESCC | establishment of protein localization to organelle | 311/8552 | 422/18723 | 3.02e-32 | 2.13e-29 | 311 |
GO:0006605111 | Esophagus | ESCC | protein targeting | 229/8552 | 314/18723 | 4.93e-23 | 1.01e-20 | 229 |
GO:0006839110 | Esophagus | ESCC | mitochondrial transport | 187/8552 | 254/18723 | 8.35e-20 | 9.81e-18 | 187 |
GO:0033108110 | Esophagus | ESCC | mitochondrial respiratory chain complex assembly | 83/8552 | 93/18723 | 9.56e-19 | 1.05e-16 | 83 |
GO:0090150110 | Esophagus | ESCC | establishment of protein localization to membrane | 182/8552 | 260/18723 | 1.27e-15 | 8.19e-14 | 182 |
GO:0072655110 | Esophagus | ESCC | establishment of protein localization to mitochondrion | 97/8552 | 120/18723 | 2.17e-15 | 1.33e-13 | 97 |
Page: 1 2 3 4 5 6 7 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SAMM50 | SNV | Missense_Mutation | c.1120N>A | p.Leu374Ile | p.L374I | Q9Y512 | protein_coding | deleterious(0.04) | benign(0.168) | TCGA-EW-A1IZ-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxotere | SD | |
SAMM50 | SNV | Missense_Mutation | rs755098914 | c.664A>C | p.Thr222Pro | p.T222P | Q9Y512 | protein_coding | tolerated(0.1) | possibly_damaging(0.676) | TCGA-EW-A1J2-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | SD |
SAMM50 | insertion | Frame_Shift_Ins | novel | c.286_287insCAGTCATTCTCAGGCTCTGTTGTCAGCTCCTTTTCCC | p.Phe96SerfsTer14 | p.F96Sfs*14 | Q9Y512 | protein_coding | TCGA-AN-A041-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
SAMM50 | SNV | Missense_Mutation | novel | c.167N>A | p.Gly56Glu | p.G56E | Q9Y512 | protein_coding | tolerated(1) | benign(0.003) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SAMM50 | SNV | Missense_Mutation | rs765107676 | c.716C>T | p.Ser239Leu | p.S239L | Q9Y512 | protein_coding | deleterious(0.01) | benign(0.211) | TCGA-EK-A2RK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD |
SAMM50 | SNV | Missense_Mutation | c.1344G>T | p.Met448Ile | p.M448I | Q9Y512 | protein_coding | tolerated(0.11) | benign(0.09) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SAMM50 | SNV | Missense_Mutation | c.383N>C | p.Leu128Ser | p.L128S | Q9Y512 | protein_coding | deleterious(0) | benign(0.355) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
SAMM50 | SNV | Missense_Mutation | novel | c.692N>A | p.Val231Glu | p.V231E | Q9Y512 | protein_coding | deleterious(0.02) | possibly_damaging(0.765) | TCGA-AA-A02R-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
SAMM50 | SNV | Missense_Mutation | novel | c.158N>C | p.Asp53Ala | p.D53A | Q9Y512 | protein_coding | deleterious(0.01) | benign(0.039) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SAMM50 | SNV | Missense_Mutation | novel | c.1055N>A | p.Ser352Asn | p.S352N | Q9Y512 | protein_coding | deleterious(0.01) | benign(0.037) | TCGA-A5-A2K3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |